{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=High+Salt&page=5", "query": { "intervention": "High Salt", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 335, "total_pages": 34, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=High+Salt&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=High+Salt&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T06:08:16.254Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00454818", "title": "Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Heart Failure, Congestive", "Dilated Cardiomyopathy" ], "interventions": [ { "name": "MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study)", "type": "GENETIC" }, { "name": "Placebo Infusion", "type": "PROCEDURE" }, { "name": "MYDICAR Phase 2 (Placebo-controlled, Randomized Study)", "type": "GENETIC" } ], "intervention_types": [ "GENETIC", "PROCEDURE" ], "sponsor": "Celladon Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 51, "start_date": "2007-03", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2014-08-20", "last_synced_at": "2026-10-25T06:08:16.254Z", "location_count": 22, "location_summary": "San Diego, California • Gainesville, Florida • Chicago, Illinois + 15 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00454818" }, { "nct_id": "NCT03563170", "title": "QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hepatocellular Carcinoma Non-resectable", "Hepatocellular Carcinoma Recurrent" ], "interventions": [ { "name": "ETBX-011", "type": "BIOLOGICAL" }, { "name": "GI-4000", "type": "BIOLOGICAL" }, { "name": "haNK for infusion", "type": "BIOLOGICAL" }, { "name": "avelumab", "type": "BIOLOGICAL" }, { "name": "Capecitabine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "5-Fluorouracil", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "nab-Paclitaxel", "type": "DRUG" }, { "name": "Sorafenib", "type": "DRUG" }, { "name": "SBRT", "type": "PROCEDURE" }, { "name": "Aldoxorubicin hydrochloride", "type": "BIOLOGICAL" }, { "name": "ETBX-051", "type": "BIOLOGICAL" }, { "name": "ETBX-061", "type": "BIOLOGICAL" }, { "name": "GI-6207", "type": "BIOLOGICAL" }, { "name": "GI-6301", "type": "BIOLOGICAL" }, { "name": "Cetuximab", "type": "DRUG" }, { "name": "N-803", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE" ], "sponsor": "ImmunityBio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2018-05-25", "completion_date": "2019-08-23", "has_results": false, "last_update_posted_date": "2021-03-18", "last_synced_at": "2026-10-25T06:08:16.254Z", "location_count": 1, "location_summary": "El Segundo, California", "locations": [ { "city": "El Segundo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03563170" }, { "nct_id": "NCT04110262", "title": "Human Sodium Balance Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "High dietary sodium intake", "type": "OTHER" }, { "name": "Low dietary sodium intake", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 52, "start_date": "2021-11-10", "completion_date": "2024-08-12", "has_results": false, "last_update_posted_date": "2024-11-29", "last_synced_at": "2026-10-25T06:08:16.254Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04110262" }, { "nct_id": "NCT01520454", "title": "Effect of Increased Free Fatty Acids on Leptin Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Leptin Resistance" ], "interventions": [ { "name": "Saline", "type": "DRUG" }, { "name": "Intralipid", "type": "DRUG" }, { "name": "Water", "type": "DIETARY_SUPPLEMENT" }, { "name": "oral fat", "type": "DIETARY_SUPPLEMENT" }, { "name": "Heparin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 26, "start_date": "2011-11", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2018-05-11", "last_synced_at": "2026-10-25T06:08:16.254Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01520454" }, { "nct_id": "NCT02292784", "title": "Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obstetric Labour, Premature" ], "interventions": [ { "name": "Retosiban", "type": "DRUG" }, { "name": "Atosiban", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Weeks", "maximum_age": "20 Weeks", "sex": "ALL", "summary": "10 Weeks to 20 Weeks" }, "enrollment_count": 98, "start_date": "2015-06-01", "completion_date": "2019-09-02", "has_results": true, "last_update_posted_date": "2020-07-09", "last_synced_at": "2026-10-25T06:08:16.254Z", "location_count": 2, "location_summary": "Park Ridge, Illinois • Galveston, Texas", "locations": [ { "city": "Park Ridge", "state": "Illinois" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02292784" }, { "nct_id": "NCT03102021", "title": "The Effect of Human Recombinant Erythropoietin in Acute Renal Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Kidney Injury" ], "interventions": [ { "name": "erythropoietin", "type": "DRUG" }, { "name": "saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "North Texas Veterans Healthcare System", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 25, "start_date": "2006-03", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2017-04-05", "last_synced_at": "2026-10-25T06:08:16.254Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03102021" }, { "nct_id": "NCT03990311", "title": "Prepared Meals to Prime and Perpetuate Reduced Dietary Sodium Intake in Hemodialysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension in Dialysis Patients", "Fluid Overload in Dialysis Patients" ], "interventions": [ { "name": "Sodium Restricted Meals", "type": "OTHER" }, { "name": "Control", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Tufts Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2019-06-05", "completion_date": "2021-12-31", "has_results": false, "last_update_posted_date": "2023-01-18", "last_synced_at": "2026-10-25T06:08:16.254Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03990311" }, { "nct_id": "NCT05831111", "title": "A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Epstein-Barr Virus Infection" ], "interventions": [ { "name": "mRNA-1195.1", "type": "BIOLOGICAL" }, { "name": "mRNA-1195.2", "type": "BIOLOGICAL" }, { "name": "mRNA-1189", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "mRNA-1195", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "ModernaTX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 482, "start_date": "2023-04-05", "completion_date": "2026-10-13", "has_results": false, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-10-25T06:08:16.254Z", "location_count": 34, "location_summary": "Anniston, Alabama • Tucson, Arizona • Huntington Beach, California + 30 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Longmont", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05831111" }, { "nct_id": "NCT02525835", "title": "Tissue Sodium in Autoimmune Disease", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Systemic Lupus Erythematosus" ], "interventions": [ { "name": "Low Dietary Sodium", "type": "DIETARY_SUPPLEMENT" }, { "name": "High Dietary Sodium", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2018-12-01", "completion_date": "2020-08", "has_results": false, "last_update_posted_date": "2018-09-25", "last_synced_at": "2026-10-25T06:08:16.254Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02525835" }, { "nct_id": "NCT05769283", "title": "Vaginal Injection of Platelet Rich Plasma for Sexual Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sexual Behavior", "Sexual Activity" ], "interventions": [ { "name": "Platelet Rich Plasma", "type": "OTHER" }, { "name": "Saline", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Medstar Health Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 52, "start_date": "2023-08-18", "completion_date": "2025-03-21", "has_results": false, "last_update_posted_date": "2025-10-22", "last_synced_at": "2026-10-25T06:08:16.254Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05769283" } ] }